Subcutaneous low-dose IL-2 for remission maintenance in elderly acute myeloid leukemia patients

MLA

Notaro, R., et al. Subcutaneous Low-Dose IL-2 for Remission Maintenance in Elderly Acute Myeloid Leukemia Patients. Jan. 1996. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3666..e20ded0e1dc2c60d893f498bc4797485&authtype=sso&custid=ns315887.

APA

Notaro, R., Selleri, C., Caparrotti, G., Picardi, M., di Grazia, C., Pagnini, D., Cantore, N., Andriani, A., Carella, M., Catalano, L., Del Vecchio, L., Di Girolamo, R., Volpe, E., Carotenuto, M., & Rotoli, B. (1996). Subcutaneous low-dose IL-2 for remission maintenance in elderly acute myeloid leukemia patients.

Chicago

Notaro, R., Carmine Selleri, G. Caparrotti, M. Picardi, C di Grazia, D. Pagnini, N. Cantore, et al. 1996. “Subcutaneous Low-Dose IL-2 for Remission Maintenance in Elderly Acute Myeloid Leukemia Patients,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3666..e20ded0e1dc2c60d893f498bc4797485&authtype=sso&custid=ns315887.